Our Team
Alp Ozalp, MP | Principal
With over 20 years of experience across manufacturing, supply chain, R&D, marketing, and field service, Alp brings a strong operational foundation and is highly motivated to source and close investments in manufacturing, B2B software, or healthcare services—leveraging his expertise and passion for driving growth in these sectors.
Currently an executive at Accuray, Alp leads the software solutions product portfolio, managing over $25 million in R&D investment. Throughout his career, he has successfully launched multiple products, driving 20% annual revenue growth and achieving a $5 million annual reduction in cost of goods sold, while leading cross-functional teams of over 100 professionals. He has also played a key role in integrating the Accuray and TomoTherapy organizations across R&D, manufacturing, and field service. Beyond his corporate role, Alp serves as Head of Partnerships at Life Science Angels, one of the largest healthcare-focused angel investment groups in the U.S., where he leads strategic collaborations, cultivates investor and industry relationships, and drives initiatives to expand LSA’s network and deal flow in life sciences and MedTech. In addition, he advises the Value Optimization Board at Quadria Capital, contributing to strategic investment initiatives in medical technology and oncology services.
Outside of work, Alp is deeply committed to community service. For over a decade, he and his wife, were youth mentors for Big Brothers Big Sisters of Dane County. Once their daughter, reached school age, Alp joined the board of the parent organization at Eagle School, serving as a board member and later vice president over a five-year period. He is a health and fitness enthusiast who enjoys cooking and sharing meals with others. Family dinners, travel, and exploring the outdoors are cherished traditions in the Ozalp household.
Peter Goodson, Advisor
Peter Goodson is a pioneer in the private equity industry, having been an early partner at Clayton, Dubilier & Rice (CD&R), one of the world’s first and most successful management buyout firms. Over four decades, CD&R has transformed over 120 companies worth more than $180 billion, generating a cumulative IRR of 53%. Peter has served on more than 15 boards and frequently stepped in as a CEO change agent to lead turnarounds and drive operational performance. Before joining CD&R, Peter was a Managing Director at Kidder, Peabody, where, at the age of 26, he founded the M&A Group in 1972. He remains one of the foremost experts in seller-advantaged exits and has led close to 1,000 corporate acquisition assignments.
Now retired from active private equity ownership, Peter is a Distinguished Teaching Fellow at UC Berkeley’s Haas School of Business, where he has received multiple awards for excellence in teaching. He also serves as a Fellow at Dartmouth’s Tuck Center for Private Equity and Entrepreneurship, INSEAD’s Global Private Equity Initiative, and the Emerging Markets Institute in Singapore. He teaches courses on M&A: Value Creation, Private Equity, and Turnarounds: Effective Leadership in Crisis, and has lectured at Harvard, Stanford, Columbia, Wharton, and NYU Stern.
Peter continues to advise private equity firms in frontier and emerging markets, focusing on value creation and operational excellence. He chairs the Value Optimization Board and Remuneration Committee at Quadria Capital, Southeast Asia and India’s largest healthcare-focused PE fund, and has held advisory roles with Mekong Capital in Vietnam and Tata Capital Growth in India.
